ÂÜÀòÂÒÂ×

Inge Marie Svane

Member of the Scientific Advisory Board at TILT Biotherapeutics

Inge Marie Svane obtained her MD from the Faculty of Health Science, University of Copenhagen, Denmark (1992) and subsequently her PhD (1997). Professor Svane has held several clinical positions during her professional career, and is currently a Consultant and Head of Immunotherapy at the Department of Oncology, Herlev University Hospital (since 2008). She is Head of disseminated melanoma treatment in Eastern Denmark, In addition, Professor Svane is Director of the Center for Cancer Immune Therapy, Herlev University Hospital (since 2006), Professor of Clinical Cancer Immunotherapy, Faculty of Health Sciences (since 2009), and Chairman of PhD Education in Clinical Cancer Research (since 2010). For the last ten years, Professor Svane has been committed to teaching and supervising undergraduates, postgraduates and postdoctoral scientists at The Faculty of Health, University of Copenhagen. Her scientific research interests are in the treatment of melanoma and immunotherapy. Professor Svane has an extensive publication record, authoring more than 100 scientific publications.